// App-Quantinova.ai

: Assessing E-RS to measure symptoms in COPD patients with a reversible component

Researchers

Presenter

  • Linda Nelsen

Principal Investigators

  • Laurie Lee

  • Wei Wu

  • Xiwu Lin

  • Dan Parks

  • Nancy Leidy

  • Steven Pascoe

Medical Centers

  • Value Evidence & Outcomes, GSK, Collegeville, PA, United States,

  • Research and Development, GSK, Stevenage, Hertfordshire, United Kingdom

  • Biostatistics, PAREXEL International, Research Triangle Park, Durham, NC, United States of America

  • Evidera, Seattle, United States of America

  • Respiratory Medicines Development Center, GSK, Research Triangle Park, Durham, NC, United States of America

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Asthma

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • Salbutamol

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved